Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitroglycerin in Moderate to Severe COVID-19
NCT04686760Completed
- Sponsor
- The University of Lahore
- Start
- Nov 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of nitroglycerin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The University of Lahore. Primary endpoints: Ratio of partial pressure of oxygen in arterial blood to fraction of inhaled oxygen and Oxygen demand. Started Nov 2020; status: completed.
02
Drugs
nitroglycerin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04686760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686760.